Anticoagulant treatment of patients with atrial fibrillation in primary health care

Author： Viitaniemi Mirjami Eskola Kari Kurunmäki Harri Latva-Nevala Anneli Wallin Anne-May Paloneva Matti Virjo Irma Ylinen Suvi Öhman Seppo Isokoski Mauri

Publisher： Informa Healthcare

ISSN： 0281-3432

Source： Scandinavian Journal of Primary Health Care, Vol.17, Iss.1, 1999-03, pp. : 59-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Objective – To determine the prevalence of anticoagulant (AC) treatment of patients with atrial fibrillation in primary health care. To identify complications in the same patients during 1 year.Design – Cross-sectional study and 1-year follow-up.Setting – Seven health centres with a total population of 164 093.Subjects – Five hundred and twenty-two anticoagulated patients with atrial fibrillation.Results – The age-adjusted prevalence of AC treated patients with atrial fibrillation was 0.30%. Of the 522 patients, 240 were men, mean age 69.6 years; and 282 women, mean age 75.1 years. At the beginning of the study 85% and after 1 year 81% of the latest prothrombin time values were within recommended range. After 1 year 414 out of the 522 patients continued AC treatment. During the 1-year follow-up 62 patients had minor or major complications. Eleven patients (2.1%) had to discontinue AC treatment because of complications. Prothrombin tests were mainly taken at 3–4 week intervals.Conclusion – High quality AC treatment is possible in the hands of general practitioners.